[1]朱竹华,许敏菊,张汀荣,等.以家庭为中心的护理模式在完全植入式静脉输液港乳腺癌化疗患者中的应用[J].西部中医药,2016,29(03):114-117.
 ZHU Zhuhua,XU Minju,ZHANG Dingrong,et al.FCC Applying to Breast Cancer Patients Who Received Chemotherapy by TIVAP[J].Western Journal of Traditional Chinese Medicine,2016,29(03):114-117.
点击复制

以家庭为中心的护理模式在完全植入式静脉输液港乳腺癌化疗患者中的应用()
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
29
期数:
2016年03期
页码:
114-117
栏目:
报道·临床护理
出版日期:
2016-03-15

文章信息/Info

Title:
FCC Applying to Breast Cancer Patients Who Received Chemotherapy by TIVAP
文章编号:
1004-6852(2016)03-0114-04
作者:
朱竹华许敏菊张汀荣黄红娣徐爱萍
东南大学医学院附属江阴医院肿瘤内科,江苏 江阴 214400
Author(s):
ZHU Zhuhua XU Minju ZHANG Dingrong HUANG Hongdi XU Aiping
Oncology Department of Affiliated Jiangyin Hospital to Medical School of Southeast University, Jiangyin 214400, China
关键词:
乳腺癌化疗以家庭为中心的护理模式完全植入式静脉输液港
Keywords:
breast cancer chemotherapy FCC mode TIVAP
分类号:
R473.7
文献标志码:
B
摘要:
目的:探讨以家庭为中心的护理(FCC)模式在完全植入式静脉输液港(TIVAP)乳腺癌化疗患者中的应用效果。方法:将TIVAP乳腺癌化疗患者40例随机分为观察组和对照组。对照组采用常规护理,观察组实施FCC模式护理,记录Zung焦虑自评量表(SAS)、抑郁自评量表(SDS)评分和自我护理能力(ESCA)评分变化情况,并比较2组患者生活质量(Karnofsky评分)。结果:护理后3、6个月,观察组SAS、SDS评分明显低于对照组(P<0.05),ESCA评分和Karnofsky评分均显著高于对照组(P<0.05)。结论:FCC模式能改善TIVAP乳腺癌化疗患者的心理健康,提高自我护理能力和生活质量。
Abstract:
Objective: To expore the effects of family-centered care (FCC) applying to breast cancer patients who received chemotherapy and total implantable venous access port (TIVAP). Methods: Forty patients were randomly separated into the observation group and the control group. The control group adopted routine care and the observation group FCC. The changes of Karnofsky scales were compared by recording SAS, SDS and ESCA. Results: In three and six months after nursing, the observation group was lower than the control group in SAS and SDS cales obviously(P<0.05), higher than the control group in ESCA scales and Karnofsky scales significantly(P<0.05). Conclusion: FCC mode could improve psychological health, selfcare nursing ability and quality of life of breast cancer patients who accepted chemotherapy and TIVAP.

相似文献/References:

[1]刘琛,吴黎雅,赵红佳,等.人参养荣汤干预乳腺癌新辅助化疗所致气血两虚证的临床研究[J].西部中医药,2011,24(11):3.
[2]周俭,葛信国,陈晓霞,等.益气通络方防治奥沙利铂神经毒性的临床观察[J].西部中医药,2011,24(11):25.
[3]李晶,刘小军,赵达△.康莱特软胶囊联合化疗治疗晚期卵巢癌的临床研究[J].西部中医药,2013,26(01):1.
 LI Jing,LIU Xiaojun,ZHAO Da.Clinical Study on KangLaiTe Soft Capsule and Chemotherapy in Treating Ovarian Cancer at Advanced Stage[J].Western Journal of Traditional Chinese Medicine,2013,26(03):1.
[4]王凤清,刘艳春.艾迪注射液联合CAG方案治疗老年急性髓细胞白血病40例疗效观察[J].西部中医药,2012,25(12):85.
 WANG Feng-qing,LIU Yan-chun.Observation on AiDi Injection and CAG Plan in Treating 40 Cases of Senile Acute Myelocytic Leukemia[J].Western Journal of Traditional Chinese Medicine,2012,25(03):85.
[5]高运来.贞芪扶正颗粒配合手术治疗颌面部肿瘤40例临床观察[J].西部中医药,2013,26(03):4.
 GAO Yunlai.Clinical Observation on Surgery and ZhenQi FuZheng Granules in Treating 40 Cases of Maxillo-facial Tumor[J].Western Journal of Traditional Chinese Medicine,2013,26(03):4.
[6]王斌,王艳杰,梁贵文,等.乳积方防治乳腺癌患者术后复发转移的临床研究*[J].西部中医药,2013,26(08):101.
 WANG Bin,WANG Yanjie,LIANG Guiwen,et al.Clinical Study on RuJiFang to Prevent Postoperative Recurrence and Metastasis of Breast Cancer[J].Western Journal of Traditional Chinese Medicine,2013,26(03):101.
[7]李树建.扶正祛积汤联合CEF化疗方案治疗晚期乳腺癌40例临床研究[J].西部中医药,2013,26(09):1.
 LI Shujian.Clinical Study on FuZheng QuJiTang Combined with CEF Chemotherapy in Treating 40 Patients Suffering from Advanced Mammary Cancer[J].Western Journal of Traditional Chinese Medicine,2013,26(03):1.
[8]王海明,崔艺馨,王琛.四磨汤口服液对胃癌术后辅助化疗胃肠道反应的影响[J].西部中医药,2014,27(06):84.
 WANG Haiming,CUI Yixin,WANG Chen.Influence of SiMoTang Oral Liquid on Gastrointestinal Responses of the Patients with Adjuvant Chemotherapy after the Surgery of Gastric Cancer[J].Western Journal of Traditional Chinese Medicine,2014,27(03):84.
[9]沈世银,周维华,陈丽萍,等.白介素-11联合循证护理对血液病化疗患者口腔黏膜炎疗效的影响[J].西部中医药,2014,27(06):126.
 SHEN Shiyin,ZHOU Weihua,CHEN Liping,et al.Influence of IL-11 and Evidence-based Nursing on Clinical Effects of Oral Mucositis of Blood Disease Patients Undergoing Chemotherapy[J].Western Journal of Traditional Chinese Medicine,2014,27(03):126.
[10]侯俊明,江静.疏肝解郁法联合化疗治疗乳腺癌临床疗效分析[J].西部中医药,2014,27(09):1.
[11]安妮,杨俊兰.消 疒徵祛积方联合化疗对晚期乳腺癌患者血清CEA、CA125、CA153和CA19-9含量及临床疗效的影响[J].西部中医药,2013,26(03):7.
 AN Ni,YANG Junlan.Effects of XiaoZhen QuJiFang and Chemotherapy on Clinical Efficacy and Contents of Serum CEA, CA125, CA153 and CA19-9 of Patients with Mammary Cancer at Advanced Stage[J].Western Journal of Traditional Chinese Medicine,2013,26(03):7.
[12]王丽,何丽娟,朱玉芹.循证护理对乳腺癌化疗患者自尊水平和应对方式的影响[J].西部中医药,2014,27(11):134.
[13]张晓华,张晓岚△,梁玉荣,等.综合心理干预对乳腺癌化疗患者医学应对方式及生命质量的影响[J].西部中医药,2015,28(07):123.

备注/Memo

备注/Memo:
作者简介:朱竹华(1972—),女,主管护师。研究方向:肿瘤疾病的临床护理。
更新日期/Last Update: 2016-03-15